Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Myriad Genetics Incorporated
Myriad Genetics Inc

Myriad Genetics Inc patents

Recent patent applications related to Myriad Genetics Inc. Myriad Genetics Inc is listed as an Agent/Assignee. Note: Myriad Genetics Inc may have other listings under different names/spellings. We're not affiliated with Myriad Genetics Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Myriad Genetics Inc-related inventors

Date Myriad Genetics Inc patents (updated weekly) - BOOKMARK this page
10/09/14Method of analyzing a brca2 gene in a human subject
04/24/14Cancer detection markers
10/24/13Method of analyzing a brca2 gene in a human subject
06/06/13Methods of detecting cancer
03/28/13Diagnostic methods involving loss of heterozygosity
03/07/13Hypoxia-related gene signatures for cancer classification
01/03/13Methods and compositions for predicting cancer therapy response
01/03/13Toxicity-associated genes, genetic variants, and use thereof
12/06/12Cancer detection markers
03/01/12Gene signatures for cancer prognosis
02/16/12Cancer biomarkers
01/19/12Methods and materials for assessing loss of heterozygosity
12/22/11Dpyd gene variants and use thereof
06/16/11Compounds for treating viral infections
03/31/11Immunizing compositions comprising hiv-1 proviral constructs with an inactive p6 gag tsg101 uev binding domain capable of producing budding-defective viral particles that remain tethered to the cell surface.
02/10/11Method of assaying 5-fu
10/07/10Composition and treating viral infection
07/29/10Tumor suppressor designated ts10q23.3
02/11/10Method of detecting large genomic rearrangements
01/21/10Therapeutic compounds and their use in cancer
11/12/09Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof
11/05/09Antiviral compounds and use thereof
10/08/09Therapeutic compounds for diseases and disorders
10/08/09Birch bark pelletization and methods for obtaining natural products from birch bark pellets
06/18/09Pharmaceutical composition and method
06/11/09Antiviral compounds
04/23/09Compounds for treating viral infections
04/16/09Compounds for diseases and disorders
04/02/09Compositions and methods for treating diseases
03/26/09Compositions and methods for treating diseases
03/12/09Pharmaceutical compositions and use thereof
03/05/09Method and composition for reducing the expression of rock-ii
02/19/09Rna interference using a universal target
02/19/09Therapeutic formulations
02/05/09Tsg101-gag interaction and use thereof
10/05/17Methods and materials for assessing homologous recombination deficiency
08/31/17Cancer biomarkers
07/13/17Genes and gene signatures for diagnosis and treatment of melanoma
06/01/17Gene signatures for cancer prognosis
05/18/17Cancer prognosis signatures
05/11/17Methods and materials for assessing allelic imbalance
04/06/17Gene signatures for cancer diagnosis and prognosis
01/26/17Methods and materials for assessing loss of heterozygosity
12/08/16Gene signatures for cancer prognosis
12/01/16Method for predicting the response and survival from chemotherapy in patients with breast cancer
09/29/16Gene signatures for renal cancer prognosis
06/09/16Methods and materials for predicting response to niraparib
05/26/16Methods and materials for assessing allelic imbalance
12/03/15Hereditary cancer diagnostics
09/03/15Gene signatures for cancer prognosis
08/20/15Cancer biomarkers
06/25/15Tumor suppressor designated ts10q23.3
06/18/15Hereditary cancer genes
06/18/15Gene signatures for cancer prognosis
06/11/15Dep2 and its uses in major depressive disorder and other related disorders
04/02/15Hereditary cancer genes
03/19/15Methods and materials for assessing loss of heterozygosity
01/15/15Methods and materials for assessing loss of heterozygosity
09/18/14Electronic variant classification
01/23/14Brca deficiency and methods of use
11/28/13Large deletions in human pms2 gene and use thereof
11/14/13Gene signatures for cancer diagnosis and prognosis
09/26/13Large deletions in human pms2 gene and use thereof
01/31/13Compositions and methods for determing cancer susceptibility
01/31/13Combination of lbh589 with other therapeutic agents for treating cancer
Patent Packs

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Myriad Genetics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Myriad Genetics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by